Unusual Malignant Transformation of Recurrent Sebaceoma. A Case Report
Heba Al-Khashnam1, Hisham Burezq2, Ibrahim Al-Aradi3, Humoud Al-Sabah4 and Khalid Al-Abdulhadi5
1Resident, Al-Babtain Center for Burns and Plastic Surgery, Ibn Sina Hospital, Sabah Health Area, State of Kuwait. 2Consultant, Plastic and Reconstructive Surgeon, Al-Babtain Center for Burns and Plastic Surgery, Ibn Sina Hospital, Sabah Health Area, State of Kuwait. 3Consultant, Surgical Dermatologist, Asaad Al-Hamad Dermatology Center, Sabah Health Area, State of Kuwait. 4Histo- pathologist, Asaad Al-Hamad Dermatology Center, Sabah Health Area, State of Kuwait. 5Chairman, Department of ENT and Head and Neck Surgery, Sabah Hospital for Head and Neck and ENT Surgery, Sabah Health Area, State of Kuwait.
Abstract
Sebaceoma is a benign tumor composed of incompletely differentiated sebaceous cells of varying degrees of maturity. Sebaceomas was never reported as a known premalignant lesion. This is a report of a sixteen year old boy who presented with a malignant transformation of a recurrent sebaceoma which was excised twice by Moh’s surgery. Excision was done with a free margin of 1 cm down to the parotid fascia. Reconstruction was performed on the same set by using cervicofascial flap extending down to the supra-clavicular area. The patient had an uneventful postoperative period apart from distal marginal necrosis of the flap, which healed nicely with conservative measures and daily dressing and was sent to our cancer centre to start his adjuvant radiotherapy. Previous literature stated that sebaceoma is a distinctive benign tumor. We have presented a case of an unusual malignant transformation of a preauricular recurrent sebaceoma. This indicates that sebaceoma does have a potential risk of malignant transformation. We believe that managing recurrent sebaceoma more aggressively with wide local excision and postoperative adjuvant radiotherapy would provide better prognosis.
Readers of this also read:
- Unusual Malignant Transformation of Recurrent Sebaceoma. A Case Report
- Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?
- Exvivo Experiments of Human Ovarian Cancer Ascites-Derived Exosomes Presented by Dendritic Cells Derived from Umbilical Cord Blood for Immunotherapy Treatment
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma – A Critical Review
- Phase II Clinical Trial of GM-CSF Treatment in Patients with Hormone-Refractory or Hormone-Naïve Adenocarcinoma of the Prostate